Difficulty: Medium
Average Score: 62%
Practice
Which of the following antidepressant agents is a selective inhibitor of norepinephrine reuptake?
Correct answer
B
Rationale
In the context of lifespan pharmacology, understanding the mechanism of action of different antidepressant agents is crucial for making informed prescribing decisions. In this question, the correct answer is B) Maprotiline, as it is a selective inhibitor of norepinephrine reuptake.
Maprotiline specifically targets the reuptake of norepinephrine, leading to increased levels of this neurotransmitter in the synaptic cleft. This action helps in alleviating symptoms of depression by enhancing norepinephrine signaling in the brain.
Now, let's discuss why the other options are incorrect:
A) Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), primarily affecting serotonin levels.
C) Amitriptyline is a tricyclic antidepressant that inhibits the reuptake of both norepinephrine and serotonin.
D) Tranylcypromine is a monoamine oxidase inhibitor (MAOI) that increases levels of norepinephrine, serotonin, and dopamine by inhibiting their metabolism.
Educationally, knowing the specific mechanisms of action of different antidepressants helps healthcare professionals tailor treatment plans to individual patient needs, taking into account factors like comorbidities, drug interactions, and potential side effects. This knowledge also aids in monitoring for therapeutic efficacy and adverse effects during treatment.
Maprotiline specifically targets the reuptake of norepinephrine, leading to increased levels of this neurotransmitter in the synaptic cleft. This action helps in alleviating symptoms of depression by enhancing norepinephrine signaling in the brain.
Now, let's discuss why the other options are incorrect:
A) Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), primarily affecting serotonin levels.
C) Amitriptyline is a tricyclic antidepressant that inhibits the reuptake of both norepinephrine and serotonin.
D) Tranylcypromine is a monoamine oxidase inhibitor (MAOI) that increases levels of norepinephrine, serotonin, and dopamine by inhibiting their metabolism.
Educationally, knowing the specific mechanisms of action of different antidepressants helps healthcare professionals tailor treatment plans to individual patient needs, taking into account factors like comorbidities, drug interactions, and potential side effects. This knowledge also aids in monitoring for therapeutic efficacy and adverse effects during treatment.